PAR 0.00% 21.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-1186

  1. 4,367 Posts.
    lightbulb Created with Sketch. 6914
    Ah yes Scotty90, I have heard of this and like the stem cell treatments this may one day be used in combo with iPPS. I believe it is a PRP type solution.

    Certainly a totally different strategy and I believe it wont have quite the widespread, mass appeal, efficacy as we are showing so far.

    Durolane is also a product that must be injected into the joint itself thus won't have the 'healing' properties for more than one (all) joints at the same time and address inflammation all over as again we have displayed..

    There was some AE's displayed in a few studies. It's not a solution for everyone though appears to have some good results as well.


    DYOR is best policy


    Reference:

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5967379/
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.